ClinicalTrials.gg
RecruitingNCT07007663Updated May 4, 2026

The Prevalence of Directional Preference in the Lumbar Stenosis Population

An observational study in Lumbar Stenosis, sponsored by NYU Langone Health. Recruiting at 1 site in United States. Open to participants aged 48 Years and older. Per ClinicalTrials.gov, last updated 2026-05-04.

Sponsored by NYU Langone Health · Observational

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 5 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
67
Ages
48 Years and older
Sex
All
01

Study summary

This will be a prospective cohort observational study observing patients with low back pain with leg pain who present for outpatient physical therapy care at Rusk Rehabilitation at NYU Langone Ambulatory Care Lake Success. Patients are eligible if they present with imaging of stenosis in their lumbar spine on MRI or CT Scan and note radicular leg symptoms with associated neurological deficits on the physical examination for at least 12 weeks.

02

Conditions studied

  • Lumbar Stenosis
03

In context

Constriction, Pathologic

456 studies on the registry are indexed under Constriction, Pathologic; 109 are open to participants now.

This study's planned enrollment of 67 is below the median of 84 across 144 observational studies indexed under Constriction, Pathologic.

Browse Constriction, Pathologic studies →

Lead sponsor

NYU Langone Health is the lead sponsor of 1,430 studies on the registry; 258 are open to participants now.

Of its 235 completed or terminated interventional studies of FDA-regulated products, 197 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
48 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients that choose to participate are undergoing a course of outpatient physical therapy care on their own accord with a referral to physical therapy. The participants have the ability to drop out or withdraw at any point of the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Neurogenic claudication (pain in the buttock, thigh, or leg during ambulation) or radicular leg symptoms with associated neurological deficits on the physical examination for at least 12 weeks.
  • Confirmatory cross-sectional magnetic resonance imaging (MRI) or computed tomography (CT) imaging demonstrating the presence of either central or lateral lumbar spinal stenosis at one or more levels was required.
  • Age >48 years old
  • Willing and able to consent
  • Scheduled to receive physical therapy that includes the collection of patients outcomes, functional tests, and may include the conduct of a two-stage treadmill test

Exclusion criteria

Exclusion Criteria:

  • Radiographic evidence of instability, degenerative spondylolisthesis, fracture, or scoliosis of more than 15°.
  • Comorbid health conditions precluding surgical management, prior lumbar surgery, progressive neurological deficit, any inflammatory conditions such as rheumatoid arthritis or indication of a potential non-musculoskeletal spinal condition (e.g., active , infection, etc.)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
67 participants (estimated)
Patient registry
No

Groups and cohorts

  • Lumbar stenosis patients

    Patients undergoing physical therapy treatment at an outpatient clinic will be enrolled. Data collection will include patient outcome measures, if directional preference is present and results from the functional tests performed by 3 licensed physical therapists who also hold their diploma in the McKenzie Method of Mechanical Diagnosis and Therapy (specialized training in recognizing directional preference) as a part of routine care (not research) for the enrolled patients. Data will be collected at initial onset, at discharge, and at a 6 months follow up.

06

What researchers measure

Primary outcomes

  1. Prevalence of directional preference (DP) among patients diagnosed with lumbar spinal stenosis (LSS)

    Prevalence is calculated as the proportion of patients with DP out of the total sample of LSS patients.

    Time frame: Baseline

  2. Prevalence of DP among patients diagnosed with LSS

    Prevalence is calculated as the proportion of patients with DP out of the total sample of LSS patients.

    Time frame: Visit 3 (variable by participant; up to Day 365)

Secondary outcomes

  1. Prevalence of Specific Directions of Directional Preference (DP) in LSS Population

    Percentage of patients with LSS demonstrating each primary DP movement direction (FLEXION, EXTENSION, or LATERAL).

    Time frame: Visit 3 (variable by participant; up to Day 365)

  2. Change in Pain Scores in LSS Patients With and Without DP

    Pain is measured using the Numeric Pain Rating Scale (NPRS), a self-report scale where individuals rate their pain level on a scale of 0 to 10, with 0 representing no pain and 10 representing the worst pain imaginable.

    Time frame: Baseline, Visit 3 (variable by participant; up to Day 365)

  3. Change in Pain Scores in LSS Patients With and Without DP

    Pain is measured using the Numeric Pain Rating Scale (NPRS), a self-report scale where individuals rate their pain level on a scale of 0 to 10, with 0 representing no pain and 10 representing the worst pain imaginable.

    Time frame: Baseline, 6 Months Post-Visit 3 (variable by participant; up to Day 365 + 6 Months)

  4. Change in Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference Score in LSS Patients With and Without DP

    The PROMIS Pain Interference questionnaire is a 40-item measure of the extent to which pain interferes with various aspects of a person's life. Each item is rated on a Likert scale from 1-5; the raw score is the sum of item responses. The raw score is standardized into an overall T-score ranging from 0-100, with a mean of 50 and standard deviation of 10. Higher scores indicate greater pain interference.

    Time frame: Baseline, Visit 3 (variable by participant; up to Day 365)

  5. Change in PROMIS - Pain Interference Score in LSS Patients With and Without DP

    The PROMIS Pain Interference questionnaire is a 40-item measure of the extent to which pain interferes with various aspects of a person's life. Each item is rated on a Likert scale from 1-5; the raw score is the sum of item responses. The raw score is standardized into an overall T-score ranging from 0-100, with a mean of 50 and standard deviation of 10. Higher scores indicate greater pain interference.

    Time frame: Baseline, 6 Months Post-Visit 3 (variable by participant; up to Day 365 + 6 Months)

  6. Change in PROMIS - Physical Function Score in LSS Patients With and Without DP

    The PROMIS Physical Function questionnaire is a 165-item measure of a patient's self-reported capability to perform functional activities, including activities of daily living (ADLs) and activities in the community. Each item is rated on a Likert scale from 1-5; the raw score is the sum of item responses. The raw score is standardized into an overall T-score ranging from 0-100, with a mean of 50 and standard deviation of 10. Higher scores indicate greater physical function.

    Time frame: Baseline, Visit 3 (variable by participant; up to Day 365)

  7. Change in PROMIS - Physical Function Score in LSS Patients With and Without DP

    The PROMIS Physical Function questionnaire is a 165-item measure of a patient's self-reported capability to perform functional activities, including activities of daily living (ADLs) and activities in the community. Each item is rated on a Likert scale from 1-5; the raw score is the sum of item responses. The raw score is standardized into an overall T-score ranging from 0-100, with a mean of 50 and standard deviation of 10. Higher scores indicate greater physical function.

    Time frame: Baseline, 6 Months Post-Visit 3 (variable by participant; up to Day 365 + 6 Months)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07007663
Lead sponsor
NYU Langone Health
Responsible party
Sponsor
First posted
Jun 6, 2025
Start date
Jun 9, 2025
Primary completion
Jun 9, 2027 (estimated)
Completion
Jun 9, 2027 (estimated)
Last update
May 4, 2026

Study contacts

Bob Chang
Contact
Bob.chang@nyulangone.org
516-467-8731
William Oswald, DPT
principal investigator · NYU Langone Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion